Adamis Pharmaceuticals Corp. buy klostergang
Start price
18.10.17
/
50%
€325.17
Target price
21.03.19
€505.12
Performance (%)
-54.95%
End price
21.03.19
€146.48
Summary
This prediction ended on 21.03.19 with a price of €146.48. Massive losses of -54.95% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - |
| iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
| iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
| iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
| iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by klostergang for this prediction
In the thread Adamis Pharmaceuticals Corp diskutieren
klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
klostergang stimmt am 18.10.2017 der fundamentalen Bewertung mit dem Ergebnis unterbewertet zu.
(Vom Mitglied beendet)